
Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

UK EIS and SEIS funds investing in early-stage biotech therapeutics and related AI

O2h Ventures runs UK tax-advantaged funds that invest in biotech and life-science companies. Its funds use the EIS and SEIS tax schemes, so they suit UK taxpayers who qualify for those reliefs. The firm warns that investors could lose all of what they put in.
UK biotech and drug-discovery companies, and investors who are high net worth or sophisticated. Prospective investors must self-certify their status before viewing the offers.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-06. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about O2h Ventures.
Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Venture firm investing in deep tech founders who turn scientific discoveries into companies

Midwest venture capital firm investing in early-stage healthcare companies, from diagnostics to life science tools

Early-stage venture investor in science and technology startups across Europe, now branded Verve Ventures

Venture capital firm investing in early-stage life sciences companies, mainly in Europe and Israel

Singapore-headquartered global investment company with a portfolio spread across five sectors
Everything here links back to the same verified catalogue. Pick your next stop.